BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21256922)

  • 1. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.
    Pedrini M; Chendo I; Grande I; Lobato MI; Belmonte-de-Abreu PS; Lersch C; Walz J; Kauer-Sant'anna M; Kapczinski F; Gama CS
    Neurosci Lett; 2011 Mar; 491(3):207-10. PubMed ID: 21256922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
    Gama CS; Andreazza AC; Kunz M; Berk M; Belmonte-de-Abreu PS; Kapczinski F
    Neurosci Lett; 2007 Jun; 420(1):45-8. PubMed ID: 17442489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.
    Grillo RW; Ottoni GL; Leke R; Souza DO; Portela LV; Lara DR
    J Psychiatr Res; 2007; 41(1-2):31-5. PubMed ID: 16546213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antipsychotics on the serum BDNF levels in schizophrenia.
    Chen CC; Huang TL
    Psychiatry Res; 2011 Oct; 189(3):327-30. PubMed ID: 21320726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
    Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
    J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia.
    Carlino D; Leone E; Di Cola F; Baj G; Marin R; Dinelli G; Tongiorgi E; De Vanna M
    J Psychiatr Res; 2011 Feb; 45(2):273-9. PubMed ID: 20630543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
    Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
    Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
    Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M
    J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of clozapine with another pharmacological agent: treatment for refractory schizophrenia in the 'real world'.
    Pai NB; Laidlaw M; Vella SC
    Acta Psychiatr Scand; 2012 Jul; 126(1):40-6. PubMed ID: 22432694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased serum neurotrophin 3 in chronically medicated schizophrenic males.
    Vargas HE; Gama CS; Andreazza AC; Medeiros D; Stertz L; Fries G; Palha J; Cereser KM; Berk M; Kapczinski F; Belmonte-de-Abreu PS
    Neurosci Lett; 2008 Aug; 440(3):197-201. PubMed ID: 18572319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
    Reis HJ; Nicolato R; Barbosa IG; Teixeira do Prado PH; Romano-Silva MA; Teixeira AL
    Neurosci Lett; 2008 Jul; 439(2):157-9. PubMed ID: 18514407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of clinical outcome in schizophrenic patients responding to clozapine.
    Mauri MC; Volonteri LS; Dell'Osso B; Regispani F; Papa P; Baldi M; Bareggi SR
    J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.
    Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Katsuki A; Hayashi K; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):308-12. PubMed ID: 20005280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
    Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L
    Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of serum BDNF levels in drug-naive patients with schizophrenia.
    Rizos EN; Rontos I; Laskos E; Arsenis G; Michalopoulou PG; Vasilopoulos D; Gournellis R; Lykouras L
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1308-11. PubMed ID: 18502013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
    Yoshimura R; Hori H; Sugita A; Ueda N; Kakihara S; Umene W; Nakano Y; Shinkai K; Mitoma M; Ohta M; Shinkai T; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1072-7. PubMed ID: 17459549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.